The Long Run with Luke Timmerman
A podcast by Timmerman Report

173 Episodes
-
Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader
Published: 7/26/2021 -
Ep94: Jenny Rooke on Investing in Biotech Tools
Published: 7/19/2021 -
Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists
Published: 6/14/2021 -
Ep92: Brad Gray on Spatial Biology
Published: 6/1/2021 -
Ep91: Daphne Zohar on Biotech Entrepreneurship
Published: 5/3/2021 -
Ep90: James Sabry on Partnering Amid Scientific Abundance
Published: 4/19/2021 -
Ep89: Emily Leproust on DNA Synthesis at Scale
Published: 3/29/2021 -
Ep88: Amy DuRoss on software and logistics for cell and gene therapy
Published: 3/15/2021 -
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
Published: 3/1/2021 -
Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease
Published: 2/9/2021 -
Ep85: Luhan Yang on CRISPR Editing for Organ Transplants
Published: 1/20/2021 -
Ep84: Steve Paul on Treatments for Mental Health
Published: 12/22/2020 -
Ep83: David Lee on Impact in Pharmaceuticals
Published: 12/14/2020 -
Ep82: Andrew Farnum on Medicines From Unusual Traits
Published: 11/23/2020 -
Ep81: Simba Gill on Microbiome Therapies
Published: 11/12/2020 -
Ep80: Peter Kolchinsky on Pharma's Soul
Published: 10/28/2020 -
Ep79: Daphne Koller on Machine Learning for Drug Discovery
Published: 10/26/2020 -
Ep78: Pearl Huang on Exoneural Cancer Biology
Published: 10/13/2020 -
Ep77: Jennifer Petter on Drugging RNA Targets
Published: 9/29/2020 -
Ep76: Otello Stampacchia on Becoming a Biotech VC
Published: 9/8/2020
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.